Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Chinese Patent Office
Novartis
US Department of Justice
Moodys
Chubb
McKesson
Medtronic
Harvard Business School
Deloitte

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076349

« Back to Dashboard
NDA 076349 describes FLUDARABINE PHOSPHATE, which is a drug marketed by Actavis Totowa, Mustafa Nevzat Ilac, Sandoz, Actavis Llc, Fresenius Kabi Usa, Mylan Labs Ltd, Sagent Pharms, and Hospira, and is included in eleven NDAs. It is available from nine suppliers. Additional details are available on the FLUDARABINE PHOSPHATE profile page.

The generic ingredient in FLUDARABINE PHOSPHATE is fludarabine phosphate. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the fludarabine phosphate profile page.

Summary for NDA: 076349

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 076349

Suppliers and Packaging for NDA: 076349

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLUDARABINE PHOSPHATE
fludarabine phosphate
INJECTABLE;INJECTION 076349 ANDA Teva Parenteral Medicines, Inc. 0703-5854 0703-5854-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-5854-01) > 2 mL in 1 VIAL, SINGLE-DOSE
FLUDARABINE PHOSPHATE
fludarabine phosphate
INJECTABLE;INJECTION 076349 ANDA Sagent Pharmaceuticals 25021-237 25021-237-06 1 VIAL in 1 CARTON (25021-237-06) > 2 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50MG/VIAL
Approval Date:Aug 28, 2003TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Mallinckrodt
QuintilesIMS
Moodys
UBS
Deloitte
Accenture
Covington
Farmers Insurance
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot